drugset / Trial / NCT06752616

Summary

The purpose of the study is to improve the pharmacological treatment of psychiatric patients with acute agitation.

Timeline

Start
2024-12-30
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 180 ug Other
Comparator Lorazepam Small molecule 4 mg Oral
Subject Midazolam Small molecule 10 mg Other

Indications

No indication recorded.